Sentinel node biopsy in head and neck squamous cell carcinoma
Authors:
- Moni Abraham KuriakoseMKMoni Abraham Kuriakose
- Nirav P TrivediNTNirav P Trivedi
- 1 April 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Otolaryngology & Head and Neck Surgery
- Vol. 17 (2) , 100-110
Abstract
Sentinel node biopsy (SNB) is emerging as a potential tool to evaluate neck node metastasis in head and neck cancer. The purpose of this article is to undertake a systemic review of published literature and to outline future directions for further studies. Existing data suggest that the status of the sentinel lymph node (SLN) predicts the pathologic stage of the nodal basin. It has been demonstrated that radiolabeled lymphoscintigraphy is superior to blue dye to localize the SLN in head and neck cancer. SLN biopsy should be recommended only in patients with previously untreated early stage (T1/2) oral cavity and orophparynx cancer with clinical N0 stage. The procedure is technique sensitive. The isolated SLN should be subjected to serial step sectioning at 150 microm and staining by hematoxylin and eosin and immunohistochemistry. Intraoperative frozen section and imprint cytology are not sensitive to identify small foci of micrometastasis and isolated tumor cells within the SLN. The clinical relevance of micrometastasis and isolated tumor cells needs to be established. It is necessary to develop a better method for intraoperative pathological confirmation of SLN metastasis. There exists no randomized clinical trial with adequate power that compares SNB and elective neck dissection in head and neck cancer. SNB in head and neck squamous cell carcinoma should be considered as an investigational tool pending validation by larger randomized clinical trials; therefore, it should not be recommended at present outside a clinical trial setting.Keywords
This publication has 88 references indexed in Scilit:
- Lymphangiogenesis and cancer metastasisNature Reviews Cancer, 2002
- Selective Neck Dissection in the Management of the Clinically Node‐Negative NeckThe Laryngoscope, 2000
- Prognostic factors and relative risk for survival in N1–3 oral squamous cell carcinoma: a multivariate analysis using Cox’s hazard modelBritish Journal of Oral and Maxillofacial Surgery, 1999
- Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissectionHead & Neck, 1999
- The Incidence of Micrometastases in Neck Dissection Specimens Obtained From Elective Neck DissectionsThe Laryngoscope, 1996
- Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancerInternational Journal of Oral and Maxillofacial Surgery, 1995
- Lymph node prognostic factors in head and neck squamous cell carcinomasThe American Journal of Surgery, 1994
- Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinomaCancer, 1993
- The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavityCancer, 1990
- The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: Treatment rationaleHead & Neck Surgery, 1984